MyFinsight
Home
Blog
About
Marketable securities
$527,882K
(47.22%↑ Y/Y)
Cash and cash
equivalents
$191,458K
(-24.55%↓ Y/Y)
Prepaid expenses and
other current assets
$23,013K
(-61.53%↓ Y/Y)
Accounts receivable
$18,739K
(-91.72%↓ Y/Y)
Inventory
$10,006K
(-2.29%↓ Y/Y)
Total current assets
$771,098K
(-16.14%↓ Y/Y)
Goodwill
$112,542K
(-0.37%↓ Y/Y)
Property and equipment,
net
$38,133K
(-70.59%↓ Y/Y)
Right-of-use asset, net
$19,842K
(-87.04%↓ Y/Y)
Other non-current
assets
$13,960K
(-34.74%↓ Y/Y)
Total assets
$955,575K
(-28.50%↓ Y/Y)
Accumulated deficit
-$4,631,026K
(-5.65%↓ Y/Y)
Treasury stock, cost
basis, 3,349,887...
$112,372K
(9.68%↑ Y/Y)
Accumulated other
comprehensive income (loss)
-$7,448K
(-1526.20%↓ Y/Y)
Total liabilities and
stockholders deficit
$955,575K
(-28.50%↓ Y/Y)
Total stockholders
deficit
-$190,707K
(-606.86%↓ Y/Y)
Additional paid-in capital
$4,558,457K
(0.80%↑ Y/Y)
Common stock, 0.01 par
value, 600,000,000...
$1,682K
(2.25%↑ Y/Y)
Total liabilities
$1,146,282K
(-11.75%↓ Y/Y)
Deferred revenue
$356,755K
(-10.65%↓ Y/Y)
Total current
liabilities
$330,574K
(-15.05%↓ Y/Y)
Long-term debt
$291,490K
Other non-current
liabilities
$165,744K
(-42.37%↓ Y/Y)
Non-current finance lease
liabilities
$1,719K
(-96.72%↓ Y/Y)
Other current
liabilities
$135,527K
(2.26%↑ Y/Y)
Deferred revenue
$86,577K
(-23.90%↓ Y/Y)
Accrued expenses
$81,424K
(-6.08%↓ Y/Y)
Accounts payable
$22,936K
(-54.67%↓ Y/Y)
Current portion of
finance lease...
$4,110K
(-25.97%↓ Y/Y)
Back
Back
Balance Sheet
NOVAVAX INC (NVAX)
NOVAVAX INC (NVAX)
source: myfinsight.com